Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials
作者: Guang NingTushar BandgarUwe HehnkeJisoo LeeJuliana C. N. Chan
作者单位: 1Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of Chinese Ministry of Health
2Seth Gordhandas Sunderdas, Medical College and King Edward Memorial Hospital
3Boehringer Ingelheim Pharma GmbH & Co. KG
4Hong Kong Institute of Diabetes and Obesity
5The Chinese University of Hong Kong, Prince of Wales Hospital
刊名: Advances in Therapy, 2017, Vol.34 (9), pp.2150-2162
来源数据库: Springer Nature Journal
DOI: 10.1007/s12325-017-0595-7
关键词: Asian patientsData poolingEfficacyEthnic groupsLinagliptinType 2 diabetesSafety
英文摘要: Asian patients with type 2 diabetes (T2D) are younger, leaner, and more likely to develop renal dysfunction than White populations. In this multiethnic analysis of data from phase 3 trials, we investigated the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in Asians stratified by these subphenotypes.
原始语种摘要: Asian patients with type 2 diabetes (T2D) are younger, leaner, and more likely to develop renal dysfunction than White populations. In this multiethnic analysis of data from phase 3 trials, we investigated the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in Asians stratified by these subphenotypes.
全文获取路径: Springer Nature  (合作)
分享到:
来源刊物:
影响因子:2.125 (2012)

×
关键词翻译
关键词翻译
  • pooling 并批
  • Analysis 分析
  • develop 发展
  • White 怀特牌汽车
  • diabetes 糖尿病
  • safety 安全
  • peptidase 肽酶
  • younger 年轻人的
  • more 更多
  • likely 大概